Table 2.
Previous systemic chemotherapy regimens
| Patient | Diagnosis | Previous systemic chemotherapy |
|---|---|---|
| 1 | MCRC | FOLFOX, bevacizumab |
| 2 | MCRC | XELIRI, bevacizumab |
| 3 | MCRC | FOLFIRI, XELOX |
| 4 | MCRC | FOLFOX, capecitabine |
| 5 | MCRC | FOLFIRI, bevacizumab |
| 6 | MCRC | FOLFIRI, bevacizumab |
| 7 | MCRC | FOLFIRI, bevacizumab |
| 8 | MCRC | IFL, FOLFOX, imatinib, paclitaxel, cetuximab, bevacizumab |
| 9 | MCRC | FOLFOX, XELIRI, bevacizumab |
| 10 | MCRC | FOLFIRI, XELOX |
| 11 | MCRC | FOLFOX, XELIRI, bevacizumab |
| 12 | Pancreatic | Gemcitabine, capecitabine with radiation |
| 13 | Pancreatic | Capecitabine with radiation, gemcitabine |
| 14 | Pancreatic | Capecitabine with radiation, gemcitabine, bevacizumab |
| 15 | Pancreatic | Gemcitabine, capecitabine with radiation |
| 16 | Pancreatic | Capecitabine with radiation, gemcitabine |
| 17 | Pancreatic | Gemcitabine |
| 18 | Pancreatic | Capecitabine with radiation, gemcitabine |
| 19 | Pancreatic | Gemcitabine, capecitabine with radiation |
| 20 | Pancreatic | Gemcitabine, capecitabine with radiation |
| 21 | Pancreatic | Gemcitabine |
| 22 | Biliary | FOLFOX, bevacizumab |
| 23 | Biliary | Gemcitabine, capecitabine, FOLFOX, bevacizumab |
| 24 | Biliary | None |
| 25 | Biliary | None |
| 26 | Gastric | Etoposide, cisplatin, 5-FU |
| 27 | Gastric | Epirubicin, oxaliplatin, capecitabine |
| 28 | Gastric | Capecitabine, oxaliplatin |
Abbreviations: MCRC = metastatic colorectal cancer; FOLFOX = folinic acid (leucovorin)/5-fluorouracil (5-FU)/oxaliplatin; XELIRI = capecitabine/irinotecan; FOLFIRI = folinic acid (leucovorin)/5-FU/irinotecan; IFL = irinotecan/folinic acid/5-FU; XELOX = capecitabine/oxaliplatin